Mercier Johanna

Mercier (Chief Comm & Corp Aff Officer) sold 28,000 shares on 2026-05-15 for $3.7M under scheduled 10b5-1 plan from 2025-02-20.

Mercier executed 4 separate sales totaling 28,000 shares for $3,676,198.56 at blended average price $131.29 on 2026-05-15, reducing her holdings by 18.2% to 125,779 shares post-transaction. This sale was conducted under a pre-arranged 10b5-1 trading plan adopted on 2025-02-20, meaning it was scheduled rather than discretionary. Prior sales at GILD on 2026-02-17 and 2025-11-17 show mixed short-term outcomes but context here is the structured, non-opportunistic nature of the current filing. GILD trades at P/E 17.48 with $7.0B quarterly revenue and +2.4% annual growth; the stock is -17.6% from its 52-week high and -5.8% over 30 days.

Mercier (Chief Comm Officer, GILD) sold 28,000 shares at avg $154.44; holds 120,288 shares post-sale.

Johanna Mercier sold 28,000 shares (18.9% of pre-transaction holdings) across three separate transactions on 2026-02-17 for a blended average price of $154.44, reducing her stake to 120,288 shares. The sales occurred near the 52-week high ($155.80), with current price at $152.74. Her same-ticker history at GILD shows 5 prior sells, none of which were well-timed at the 90-day mark; the most recent sales in November 2025 and August 2025 were followed by positive 90-day returns of +23.2%, +22.8%, +5.2%, and +5.6%, indicating the stock rose after her previous exits. While Mercier's cross-ticker track record shows an average 90-day return of +10.0% after sells with a 0.00% well-timed rate, her consistent pattern of selling into strength at this ticker, combined with prior unsuccessful timing calls, provides limited signal about near-term direction.

CCO Mercier Johanna sold 28.0K shares at blended avg $125.86 on 2025-11-17 for $3.5M; retains 107.2K shares.

Mercier executed 2 separate sales totaling 28,000 shares for $3,524,173.42, reducing her post-transaction holdings to 107.2K shares, a -20.7% reduction from her pre-transaction position of 135.2K shares. The sale occurred at a blended average price of $125.86, which is 1.0% below the current price of $127.18 and near the 52-week high of $127.18. At the same ticker, her 5 prior open-market sells have shown a 0% well-timed rate, with 90-day returns averaging +5.2% to +5.6%—meaning the stock rose after her prior sales, indicating poor timing on those occasions. This sale occurs within a context where Gilead's P/E is 19.45, revenue growth is +6.0% annually, and the company posted $3.1B net income on $7.8B quarterly revenue. The sale is material in size relative to her remaining holdings, though her cross-ticker track record shows limited historical success in predicting subsequent price movements.

GILD: Chief Commercial Officer Mercier sold 28,000 shares for $3.3M on 2025-08-15 at blended avg $118.53

Johanna Mercier, Chief Commercial Officer at Gilead Sciences, executed 6 separate sales totaling 28,000 shares for $3,318,926.70 on 2025-08-15, reducing her holdings by 19.7% to 114,168 shares. The blended average sale price of $118.53 is near the current price of $117.99 and within recent trading range ($73.78–$120.47 52-week). Across her SAME-TICKER history at GILD, prior sales have not been well-timed—0 of 2 measurable 90-day outcomes were negative—suggesting the stock has risen after her prior exits. No FLAGS appear in this filing, so the timing pattern is material to interpretation.

CCO Mercier Johanna sold 28,000 shares at $107.52 ($3.0M) on 2025-05-22; reduces stake by 18.8%

Chief Commercial Officer Johanna Mercier executed three separate sales totaling 28,000 shares for $3,010,563.60 at $107.52 per share, reducing her stake from 149,152 to 121,152 shares (an 18.8% reduction). At the current price of $107.37, the stock is -8.6% from its 52-week high of $117.41. Her prior two sales at GILD (2024-09-12) posted 90-day returns of +9.7% and +11.0%, indicating the stock subsequently appreciated after those exits; neither was well-timed on the downside. Gilead is valued at 22.37 P/E with $6.7B quarterly revenue and +6.0% annual growth, and the stock has moved +0.9% over 30 days and -2.4% over 90 days—showing volatility near recent lows but no clear directional confirmation of her sale timing.

GILD CCO Mercier sells 29,357 shares (27.3% of holdings) for $2.5M at $83.78–$84.23 blended on 2024-09-12

Johanna Mercier, Chief Commercial Officer of Gilead Sciences, executed 2 separate sales totaling 29,357 shares for $2,459,576.75, reducing her holdings by 27.3% to 78,127 shares. The sales occurred at prices ($84.23 and $83.25) slightly above the current price of $82.81, within a 52-week range of $63.15–$87.29, suggesting execution near recent market levels rather than at valuation extremes. With the stock up 11.7% over 30 days and 27.3% over 90 days, the timing does not represent capitulation; however, the magnitude of the reduction (nearly one-third of prior holdings) reflects a material decrease in Mercier's direct stake in the company. Gilead's current trading multiple (P/E of 97.42) remains elevated relative to growth metrics (flat annual revenue growth of -0.6%), a context worth noting when evaluating changes in executive positioning.